fashion -WSS

fashion

author：leisure time 2025-10-02 23:48:14 - browse：6

The headquarter of Biotechnology company Ionis Pharmaceuticals, consists of glass windows, pale yellow exteriors and plants outside the building — biotech coverage from STAT — courtesy Ionis Pharmaceuticals

Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on Friday that a pair of late-stage trials showed that its experimental therapy for hereditary angioedema benefitted patients — including those taking drugs currently on the market.

In one of the Phase 3 trials, dubbed OASIS, patients with hereditary angioedema, a rare disease characterized by severe bouts of swelling, were given injections of donidalorsen either monthly or every two months. Those in the former group had an 81% lower monthly rate of swelling attacks after 25 weeks than patients given a placebo, while the reduction compared to placebo was 55% for those treated every two months.

The other study, OASISplus, found that donidalorsen’s benefits deepened and converged after up to an additional year of treatment, with swelling attack rates dropping by 92% to 93% regardless of how often patients were dosed. Notably, this study also tracked patients who switched over to donidalorsen from existing therapies meant to prevent swelling attacks, including drugs sold by Takeda and BioCryst Pharmaceuticals. Patients who switched to the Ionis drug saw their swelling attack rates drop by 62% compared to previous treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： 1 dead, 9 hurt in July 4th fireworks explosion

knowledge

WSS

Churchill Downs extends trainer Bob Baffert's ban through 2024

How artificial intelligence is being used to detect, treat cancer

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

White House launches permanent pandemic office

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

As demand for Covid shots wanes, Moderna seeks its next success

CDC backtracks, saying fully vaccinated people can go maskless indoors

How to save PrEP access — and even expand it

3 killed, 8 injured in late

Malaria cases in Florida and Texas: Here’s what you need to know

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Medical records are filled with copy

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Review: 'Barbie' will hit you like a shot in the heart

leisure time

CDC backtracks, saying fully vaccinated people can go maskless indoors

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Our daughter's deadly disease: trisomy 18. We wanted to protect her

1 dead, 9 hurt in July 4th fireworks explosion

Leon Gautier, last member of French D

FDA official pushes for dedicated emerging pathogens team

focus

hotspot

knowledge

Wikipedia